Phase I/IIa trials of a novel T-cell epitope-based peptide therapy for peanut allergy

O'Hehir, Robyn (Primary Chief Investigator (PCI))

Immunology Alfred Hospital

Project: Research

Status	Finished
Effective start/end date	1/01/16 → 31/12/18

Funding

NHMRC - National Health and Medical Research Council (Australia): A$1,440,000.00

1 Article

Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy
Voskamp, A. L., Khosa, S., Phan, T., DeBerg, H. A., Bingham, J., Hew, M., Smith, W., Abramovitch, J., Rolland, J. M., Moyle, M., Nadeau, K. C., Lack, G., Larché, M., Wambre, E., O'Hehir, R. E., Hickey, P. & Prickett, S. R., Feb 2023, In: Allergy. 79, 2, p. 485-498 14 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

17 Citations (Scopus)